Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial

Open access

Abstract

Background Deep brain stimulation (DBS) of the subcallosal cingulate white matter has shown promise as an intervention for patients with chronic, unremitting depression. To test the safety and efficacy of DBS for treatment-resistant depression, a prospective, randomised, sham-controlled trial was conducted.Methods Participants with treatment-resistant depression were implanted with a DBS system targeting bilateral subcallosal cingulate white matter and randomised to 6 months of active or sham DBS, followed by 6 months of open-label subcallosal cingulate DBS. Randomisation was computer generated with a block size of three at each site before the site started the study. The primary outcome was frequency of response (defined as a 40% or greater reduction in depression severity from baseline) averaged over months 4-6 of the double-blind phase. A futility analysis was performed when approximately half of the proposed sample received DBS implantation and completed the double-blind phase. At the conclusion of the 12-month study, a subset of patients were followed up for up to 24 months. The study is registered at ClinicalTrials.gov, number NCT00617162.Findings Before the futility analysis, 90 participants were randomly assigned to active (n=60) or sham (n=30) stimulation between April 10, 2008, and Nov 21, 2012. Both groups showed improvement, but there was no statistically significant difference in response during the double-blind, sham-controlled phase (12 [20%] patients in the stimulation group vs five [17%] patients in the control group). 28 patients experienced 40 serious adverse events; eight of these (in seven patients) were deemed to be related to the study device or surgery.Interpretation This study confirmed the safety and feasibility of subcallosal cingulate DBS as a treatment for treatment-resistant depression but did not show statistically significant antidepressant efficacy in a 6-month double-blind, sham-controlled trial. Future studies are needed to investigate factors such as clinical features or electrode placement that might improve efficacy.Funding Abbott (previously St Jude Medical).

Overview

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(17)30371-1

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 25 references

Cited by

See all 577

Metadata

Authors
Holtzheimer, P. E., Husain, M. M., Lisanby, S. H., Taylor, S. F., Whitworth, L. A., McClintock, S., Slavin, K. V., Berman, J., McKhann, G. M., Patil, P. G., Rittberg, B. R., Abosch, A., Pandurangi, A. K., Holloway, K. L., Lam, R. W., Honey, C. R., Neimat, J. S., Henderson, J. M., DeBattista, C., Rothschild, A. J., Pilitsis, J. G., Espinoza, R. T., Petrides, G., Mogilner, A. Y., Matthews, K., Peichel, D., Gross, R. E., Hamani, C., Lozano, A. M., & Mayberg, H. S.
Affiliations
  • Dartmouth–Hitchcock Medical Center (US)
  • Duke University (US)
  • National Institutes of Health (US)
  • University of Michigan (US)
  • The University of Texas Southwestern Medical Center (US)
  • University of Illinois Chicago (US)
  • Columbia University (US)
  • NewYork–Presbyterian Hospital (US)
  • University of Minnesota (US)
  • University of Colorado Anschutz (US)
  • Virginia Commonwealth University (US)
  • University of British Columbia (CA)
  • University of Louisville (US)
  • Stanford Medicine (US)
  • UMass Memorial Health Care (US)
  • Albany Medical College (US)
  • University of California, Los Angeles (US)
  • Northwell Health (US)
  • NYU Langone Health (US)
  • University of Dundee (GB)
  • Emory University (US)
  • Centre for Addiction and Mental Health (CA)
Corresponding author
Holtzheimer, Paul E
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2017-11
Volume
4
Issue
11
Pages
839-849
ISSN
2215-0366 (ISSN-L)
OpenAlex
W2763173694
Cited by
577
References
25
Citations by year
2026: 52 · 2025: 44 · 2024: 72 · 2023: 66 · 2022: 62 · 2021: 79 · 2020: 68 · 2019: 63 · 2018: 65 · 2017: 4
FWCI
38.07
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc-nd)
Funders
  • American Epilepsy Society
  • Janssen Pharmaceuticals
  • Pfizer
  • Jazz Pharmaceuticals
  • National Science Foundation
  • GlaxoSmithKline
  • Stanley Foundation
  • National Institutes of Health
  • Medtronic
  • H. Lundbeck A/S
  • A. Alfred Taubman Medical Research Institute
  • Abbott Laboratories
  • Boston Scientific Corporation
  • National Institute on Aging
  • Hope for Depression Research Foundation
  • Canadian Institutes of Health Research
  • National Institute of Neurological Disorders and Stroke
  • Allergan
  • Biotronik
  • Defense Advanced Research Projects Agency
  • Takeda Pharmaceutical Company
  • Brain and Behavior Research Foundation
  • Rare Disease Foundation
  • Baxter International
  • GE Global Research
  • National Institute on Drug Abuse
  • St. Jude Medical
  • NeuroPace
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
deep brain stimulation, subcallosal cingulate, treatment-resistant depression, chronic depression, antidepressant efficacy, futility analysis, electrode placement
MeSH terms
Adult, Feasibility Studies, Female, Gyrus Cinguli, Humans, Male, Middle Aged, Placebos, Prospective Studies, Outcome Assessment, Health Care, Deep Brain Stimulation, Depressive Disorder, Treatment-Resistant, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. https://app.cochat.ai/papers/10.1016/s2215-0366(17)30371-1
The paper
Holtzheimer, P. E., Husain, M. M., Lisanby, S. H., Taylor, S. F., Whitworth, L. A., McClintock, S., Slavin, K. V., Berman, J., McKhann, G. M., Patil, P. G., Rittberg, B. R., Abosch, A., Pandurangi, A. K., Holloway, K. L., Lam, R. W., Honey, C. R., Neimat, J. S., Henderson, J. M., DeBattista, C., . . . Mayberg, H. S. (2017). Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(17)30371-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.